TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hematologic Disease
New hematologic disease research from University of Texas described
May 6th, 2008
"Invasive aspergillosis (IA) is a major cause of morbidity and mortality in patients with hematologic malignancy (HM). There are 2 lipid formulations of amphotericin B (AMB) currently in widespread use: AMB lipid complex (ABLC) and liposomal AMB (L-AMB)," scientists writing in the journal Cancer report. "There are limited data comparing the efficacy and safety of these 2 agents in the treatment of IA in patients with cancer. The authors retrospectively studied 381 consecutive patients with HM who had proven or probable IA (according to European Organization for Research and Treatment of Cancer/Mycosis Study Group of the National Institute of Allergy and...
Source: TB & Outbreaks Week (2008-05-06)
|
